JD Health International Inc.
Simbols: JDHIY
PNK
3.42
USDTirgus cena šodien
24.5068
P/E koeficients
0.1671
PEG koeficients
11.66B
MRK Cap
- 0.00%
DIV ienesīgums
JD Health International Inc. (JDHIY) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 41236.6 | 46966.2 | 41990.1 | |||||||
balance-sheet.row.short-term-investments | 0 | 26184.2 | 28248.5 | 24737.8 | |||||||
balance-sheet.row.net-receivables | 0 | 955.7 | 2727.3 | 665.5 | |||||||
balance-sheet.row.inventory | 0 | 5571.5 | 5996.3 | 3041.2 | |||||||
balance-sheet.row.other-current-assets | 0 | 86 | 757.4 | 8.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 47849.9 | 56447.2 | 45705.5 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 741.4 | 251.9 | 260.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 2182.2 | 2268 | 25.4 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 2182.2 | 2268 | 25.4 | |||||||
balance-sheet.row.long-term-investments | 0 | 13212.8 | -26625.3 | -23558.9 | |||||||
balance-sheet.row.tax-assets | 0 | 299.8 | 208.5 | 95.9 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 2.2 | 28727.1 | 25473.6 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 16438.4 | 4830.1 | 2296.7 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 64288.3 | 61277.3 | 48002.2 | |||||||
balance-sheet.row.account-payables | 0 | 9660.5 | 10526 | 5485.1 | |||||||
balance-sheet.row.short-term-debt | 0 | 99.8 | 70.6 | 67.6 | |||||||
balance-sheet.row.tax-payables | 0 | 337.5 | 380.2 | 133.5 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 119.4 | 128.8 | 133.7 | |||||||
Deferred Revenue Non Current | 0 | -213.6 | -7.8 | -8.9 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 4043.5 | 3799.1 | 1790.4 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 333 | 136.6 | 142.6 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 119.4 | 199.4 | 201.3 | |||||||
balance-sheet.row.total-liab | 0 | 14918 | 16492.7 | 8147.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.retained-earnings | 0 | -17336 | -19382.1 | -19714.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 8233.1 | 7133.8 | 3377.1 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 58458.7 | 57028.5 | 56191.1 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 49355.8 | 44780.2 | 39853.4 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 64288.3 | 61277.3 | 48002.2 | |||||||
balance-sheet.row.minority-interest | 0 | 14.5 | 4.3 | 1.2 | |||||||
balance-sheet.row.total-equity | 0 | 49370.3 | 44784.6 | 39854.6 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 39397 | 1623.2 | 1178.9 | |||||||
balance-sheet.row.total-debt | 0 | 219.3 | 199.4 | 201.3 | |||||||
balance-sheet.row.net-debt | 0 | -14833.1 | -18518.3 | -17051 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 2141.8 | 383.2 | -1072.8 | |||||||
cash-flows.row.depreciation-and-amortization | 0 | 227.5 | 140.7 | 63.2 | |||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 1272.8 | 329.4 | |||||||
cash-flows.row.stock-based-compensation | 0 | 1847.8 | 2104.3 | 2579.7 | |||||||
cash-flows.row.change-in-working-capital | 0 | 0 | 2849.1 | 2027.2 | |||||||
cash-flows.row.account-receivables | 0 | 0 | -685.1 | -331.4 | |||||||
cash-flows.row.inventory | 0 | 0 | -3151.4 | -1286.2 | |||||||
cash-flows.row.account-payables | 0 | 0 | 5041 | 2585.5 | |||||||
cash-flows.row.other-working-capital | 0 | 0 | 1644.6 | 1059.3 | |||||||
cash-flows.row.other-non-cash-items | 0 | 387.7 | -845 | -495.9 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -2273 | -518.2 | |||||||
cash-flows.row.acquisitions-net | 0 | 0 | -3 | -7.9 | |||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -33058 | -46325.4 | |||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 31103.8 | 29078.1 | |||||||
cash-flows.row.other-investing-activites | 0 | -8022.9 | -5.4 | 21.1 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -8022.9 | -4235.5 | -17752.2 | |||||||
cash-flows.row.debt-repayment | 0 | 0 | -47.6 | -32.3 | |||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -869 | -126.4 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | 0 | -117.2 | -56.4 | -37.2 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -117.2 | -925.4 | -163.7 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -145.4 | 721.3 | -533.4 | |||||||
cash-flows.row.net-change-in-cash | 0 | -3698.3 | 1465.4 | -15018.5 | |||||||
cash-flows.row.cash-at-end-of-period | 0 | 15052.4 | 18717.7 | 17252.3 | |||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 18750.7 | 17252.3 | 32270.8 | |||||||
cash-flows.row.operating-cash-flow | 0 | 4604.8 | 5905.1 | 3430.7 | |||||||
cash-flows.row.capital-expenditure | 0 | 0 | -2273 | -518.2 | |||||||
cash-flows.row.free-cash-flow | 0 | 4604.8 | 3632.2 | 2912.6 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 53529.9 | 46736.2 | 30682.3 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 41664.6 | 36844.6 | 23485 | |||||||
income-statement-row.row.gross-profit | 0 | 11865.3 | 9891.5 | 7197.3 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 193.7 | 82.5 | 145.1 | |||||||
income-statement-row.row.operating-expenses | 0 | 11234.5 | 9938.4 | 8563 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 52899.1 | 46783.1 | 32048 | |||||||
income-statement-row.row.interest-income | 0 | 1949 | 864.3 | 457.6 | |||||||
income-statement-row.row.interest-expense | 0 | 9.5 | 9.1 | 6 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2133.3 | -107.3 | -44.4 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 193.7 | 82.5 | 145.1 | |||||||
income-statement-row.row.total-operating-expenses | 0 | 2133.3 | -107.3 | -44.4 | |||||||
income-statement-row.row.interest-expense | 0 | 9.5 | 9.1 | 6 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 227.5 | 140.7 | 63.2 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 630.8 | 803.1 | -857.1 | |||||||
income-statement-row.row.income-before-tax | 0 | 2764.1 | 695.8 | -901.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 550.5 | 312.6 | 171.3 | |||||||
income-statement-row.row.net-income | 0 | 2141.8 | 380.1 | -1073.5 |
Biežāk uzdotie jautājumi
Kas ir JD Health International Inc. (JDHIY) kopējie aktīvi?
JD Health International Inc. (JDHIY) kopējie aktīvi ir 64288300000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.222.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 2.132.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.040.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.012.
Kāda ir JD Health International Inc. (JDHIY) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 2141841000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 219266000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 11234488000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.